This indicates that, although MMP3 is associated with the pathogenesis of tendinopathy, and polymorphisms in this gene are associated with the risk of its occurrence, this does not translate into an association with the effectiveness of tendinopathy treatment using platelet-rich plasma. This evidence concerns the gene MMP3 and disease of the tendon.